Category: Press Releases

Categories
Cannabis Events Press Releases

Earth Science Tech LTD (ETST) Considers Dual Listing of its Common Shares on the Canadian Securities Exchange (CSE)

DORAL, Florida, Dec. 11, 2018 (GLOBE NEWSWIRE)

Earth Science Tech LTD. (OTCQB: ETST) (“ETST” or the “Company”), an innovative biotech company focused on the cannabidiol (CBD), nutraceutical and pharmaceutical fields, medical devices, and research and development, today announces that as the Company is now an “OTC reporting issuer” in the Province of Québec, Canada, its board of directors is considering a dual listing of its common shares on the Canadian Securities Exchange (CSE).

Earth Science intends to file an application with the CSE in early 2019. Listing could happen as early as in the third quarter of the Company’s current fiscal year and would require certain regulatory approvals that would allow Earth Science to market and sell its common shares to Canadian investors.

“The Canadian Securities Exchange has seen significant increases in trading, particularly in the cannabis and CBD space. We feel that by listing on the two exchanges we will attract more investors in both the U.S. and Canada, creating further liquidity and increasing our ability to raise capital in a different market. With our R&D operations conducted in Canada and our CEO residing in Canada, considering a listing on the CSE makes the most sense,” states Earth Science president, director and Chairman Nickolas S. Tabraue.

Categories
In the News Latest News Press Releases

Earth Science Tech LTD (ETST) Introduces New Chief Operations Officer, (COO), Achieving Q1 Goal

Royalty-free clipart picture of a 3d red and white business plan word collage, on a shaded background.

DORAL, FL – March 20, 2018 via (GLOBE NEWSWIRE) –

Earth Science Tech LTD (OTC: ETST) (“ETST” or the “Company”), an innovative biotech company focused on the cannabidiol (CBD), nutraceutical and pharmaceutical fields, as well as on R&D for certain medical devices, today announces new COO, Gagan Hunter, Achieving Q1 Goal of February.

The Company’s current President, Director, and COO, Nickolas Tabraue, alleviates his role as COO to Gagan. Mr. Hunter will use his excessive experience and skill sets to maintain the Company operations in order and efficient while expanding and progressing. While Mr. Tabraue continues his roles as President and Director to concentrate implementing the Company’s growth strategy and further build the Company.

A graduate of Oaksterdam University, America’s first primer cannabis college, University of Pittsburgh, and post graduate studies at the Temple University, Gagan Hunter is a holistic health specialist, cannabis & cannabinoid (CBD) educator. Mr. Hunter has 20 years of natural products industry experience in sales, marketing, and management, and 20 years teaching nutrition. His skills obtained through his 20 years in the industry are staff training, purchasing, customer service, inventory control, and financial management.

The new COO, shares his first statement with, “ I’m truly excited to be part of the Earth Science Tech LTD team, I have known and worked with Jill Buzan for over 17 years and Gabe for 5 years. Being part of the Company truly makes me feel at home and part of the family. I look forward on strengthening the Company’s operations and making sure the efficiency stay consistent as the growth continues.”

Nickolas Tabraue, ends with, “I feel that we finally have the last piece of our puzzle in place to take ETST to new heights. Gagan has many great ideas to implement that’ll help the Company work more efficiently and organized. We now have every major role managed by passionate like minded individuals to truly make ETST the innovative trusted brand in the alternative medicine space. I plan on sharing updates on our audit, Tier II Reg A+, up-listing, and other working matters as soon as they progress.”

About Earth Science Tech (ETST)

Earth Science Tech has among the highest quality, purity and full-spectrum high-grade hemp CBD (cannabidiol) oil on the market. Made using the superior supercritical CO2 liquid extraction, ETST’s CBD oil is 100% natural and organic. The company’s research, performed alongside the University of Central Oklahoma and DV Biologics laboratory, demonstrates that ETST is the top nutritional and dietary supplement brand for high-grade hemp CBD oil.

To learn more and to buy CBD Hemp Oil, please visit: www.earthsciencetech.com

Categories
In the News Latest News Press Releases Top Stories

Earth Science Tech LTD (ETST) Achieves Highest Sales Revenue Month of February

DORAL, FL March 14, 2018 via (GLOBE NEWSWIRE) –

Earth Science Tech LTD (OTC: ETST) (“ETST” or the “Company”), an innovative biotech company focused on the cannabidiol (CBD), nutraceutical and pharmaceutical fields, as well as on R&D for certain medical devices, today announces highest sales revenue month of February.

As anticipated, February the Company achieved the highest sales revenue month with sales of $75,981.02 a 90% revenue increase compared to last year’s $39,881.99 February 2017. This achievement is due to the Company’s new veteran Chief Sales Officer, (CSO) and revamp CBD line. March has already started strong and is headed to be high revenue month leading to the Company’s highest revenue fiscal year.

Jill Buzan, ETST’s CSO states, “my first month with the company has been an amazing experience with so much potential. I’m excited to see that we were able to achieve the highest revenue month to date, especially due to product delivery delays and slight errors made from the manufacture. Starting the month of March with our full inventory and all errors corrected we’ll be able to truly take Earth Science Tech LTD to new heights.”

The Company’s President, Director, & COO ends with, “February looked to be our pivotal month having the honor of having Jill Buzan as our CSO, transitioning Gabriel Aviles to our Chief Learning Officer, (CLO), and our new revamped CBD line. Jill Buzan has brought so much to our company, with her experience and knowledge Earth Science Tech LTD truly looks to stay innovative and be the trusted CBD brand in the industry. Gabriel Aviles has started recored live one hour videos from Monday to Friday from 1pm-2pm on our youtube channel and his videos will start being shared throughout social media. Our new product revamp has been successful despite the manufacturing delays and minor errors due to the increasing product demand leading us to rush the process. We are already working on our next batch improving our essential oils, providing our manufacture to have time to eliminate any potential errors and preventing backorders.”

Mr. Tabraue continues, “our audit continues to move forward and looks to be finalized within the month of March and be used to submit our planned Tier II Regulation A+ as well our planned OTCQB up-listing. The team and I greatly appreciate our stakeholder’s loyalty, trust, and support while growing with us. We plan on sharing updates as they progress.”

About Earth Science Tech LTD (ETST)

Earth Science Tech has among the highest quality, purity and full-spectrum high-grade hemp CBD (cannabidiol) oil on the market. Made using the superior supercritical CO2 liquid extraction, ETST’s CBD oil is 100% natural and organic. The company’s research, performed alongside the University of Central Oklahoma and DV Biologics laboratory, demonstrates that ETST is the top nutritional and dietary supplement brand for high-grade hemp CBD oil.

To learn more and to buy CBD Hemp Oil, please visit: www.earthsciencetech.com

Categories
Cannabis Oils Drug Addiction Hemp Oil In the News Latest News Medical Opioid Addiction Press Releases

Earth Science Tech Finalizes Plans for Human Trials on New CBD-Based Formula Targeting Opioid Addiction Epidemic

98190781 - an ampoule opioid next to it is a note written in german opioid epidemic. all around, many tablets and syringes are scattered.

Doral, FL, February 28, 2018 (GLOBE NEWSWIRE) – Earth Science Tech (OTC PINK: ETST) (“ETST” or the “Company”), an innovative biotech company focused on the cannabinoid (CBD), nutraceutical and pharmaceutical fields, as well as on R&D for certain medical devices, today announced it has finalized plans for a 9-month human trial to assess the efficacy of its treatment combining an essential mineral element and full-spectrum cannabinoid industrial hemp oil. This is expected to increase potency as opposed to the status quo in the market today, which consists solely of essential mineral element therapy (monotherapy) in treating patients with morbid substance abuse and/or dependence. These plans were originally announced in late 2017. The purpose of this trial is to develop a methodology for treating opioid addicts, preventing fatal overdoses, and relieving side-effects from withdrawals.

The new study takes advantage of two of the properties of ETST’s full-spectrum cannabinoids industrial hemp oil that have already shown great success against addiction, based on positive feedback from customers and doctors alike. The full-spectrum cannabinoids has great potential to mix with the essential mineral element, because it can support and increase the action of other drugs and medicinal substances, offering tremendous synergy. Many promising clinical studies are ongoing around the world, with cannabinoids being a key research topic for the substance abuse treatment and psychological disorders.

The 9-month human trial will study substance abuse patients who had drug prescription treatment or dietary supplement monotherapy, full-spectrum cannabinoid monotherapy, and a combination of full-spectrum cannabinoids and a dietary supplement molecule. The patient will receive this treatment sequentially. The first three months with drug prescription treatment monotherapy or dietary supplement monotherapy, the second three months with drug prescription or dietary supplement combined with full-spectrum cannabinoids, and the last 3 months with full-spectrum cannabinoids and hemp oil.  

The choice of the molecule that will be combined with the full-spectrum cannabinoids have selected after months of meticulous due diligence. The project will test the additive nature of full-spectrum cannabidnoids with two different forms of an essential mineral element, which will be revealed soon.

Should the potential synergies between the essential mineral element and cannabinoids (mainly CBD) prove successful, as the company is confident that it will, then ETST will be positioned to bring an innovative new products to the marketplace to counteract the scourge of opioid deaths that is sweeping the US. Earth Science Tech envisions and plans on producing a nutraceutical product that could be sold over the counter to help addicts resist cravings, and a cannabinoid companion for a generic drug to make the treatment more effective and reduce the danger, toxicity, and side-effects.

The Company’s CLO, Gabriel Aviles, and CEO/CSO, Dr. Michel Aube, will be supervising the project along with the medical professional advisory board team providing their resources for the human trials. The project time frame and goal is set to be completed, along with white paper studies by early 2019. This will encourage the Company to pursue clinical studies for at least two years through the remainder of 2019 and 2020, pioneering the never before attempted research studies on these two compounds combined.

ETST is currently communicating with their third-party CGMP laboratory on  mixing the anti-opioid formula for human trials, and are in talks with rehab centers interested in participating in the study to some capacity. The Company plans on sharing updates as they progress.

 

About Earth Science Tech (ETST): Earth Science Tech has among the highest quality, purity and full-spectrum high-grade hemp CBD (cannabidiol) oil on the market. Made using the superior supercritical CO2 liquid extraction, ETST’s CBD oil is 100% natural and organic. The company’s research, performed alongside the University of Central Oklahoma and DV Biologics laboratory, demonstrates that ETST is the top nutritional and dietary supplement brand for high-grade hemp CBD oil.

To learn more and to buy CBD Hemp Oil, please visit: www.earthsciencetech.com

 

About Earth Science Pharmaceutical: Earth Science Pharmaceutical, Inc. is a wholly owned subsidiary of Earth Science Tech (ETST). Earth Science Pharmaceutical is focused on becoming a world leader in the development of low cost, non-invasive diagnostic tools, medical devices, testing processes and vaccines for STIs (sexually transmitted infections and/or diseases). Earth Science Pharmaceutical CEO Dr. Michel Aubé, a renowned scientist, is committed to help grow ETST in the medical and pharmaceutical industry.

To learn more please visit: www.EarthSciencePharmaceutical.com

About Cannabis Therapeutics: Cannabis Therapeutics, Inc. is a wholly owned subsidiary of Earth Science Tech (ETST). Cannabis Therapeutics was formed as an emerging biotechnology company poised to become a world leader in cannabinoid research and development for a broad line of cannabis cannabinoid-based pharmaceuticals, nutraceuticals, as well as other products & solutions. Cannabis Therapeutics’ mission it to help change the health care landscape by introducing its proprietary cannabis-cannabinoid-based products made for both the pharmaceutical and retail consumer markets worldwide.

To learn more please visit: www.CannabisThera.com

About KannaBidioiD: KannaBidioid, Inc. is wholly owned subsidiary of Earth Science Tech (ETST). KannaBidioid is focused in the recreational space to manufacture and distribute vapes/e-liquids and gummy edibles in the recreational space formulated by its unique Kanna and CBD formula. Kanna and CBD synergistically enhance one another, providing optimal relaxation, an uplifting sensation, enhance focus, and help with nicotine addiction based on their properties.

To learn more please visit: www.KannaBidioiDInc.com

SAFE HARBOR ACT: Forward-Looking Statements are included within the meaning of Section 27A of the Securities Act of 1933, and Section 21E of the Securities Exchange Act of 1934, as amended. All statements regarding our expected future financial position, results of operations, cash flows, financing plans, business strategy, products and services, competitive positions, growth opportunities, plans and objectives of management for future operations, including words such as “anticipate,” “if,” “believe,” “plan,” “estimate,” “expect,” “intend,” “may,” “could,” “should,” “will,” and other similar expressions are forward-looking statements and involve risks, uncertainties and contingencies, many of which are beyond our control, which may cause actual results, performance, or achievements to differ materially from anticipated results, performance, or achievements. We are under no obligation to (and expressly disclaim any such obligation to) update or alter our forward-looking statements, whether as a result of new information, future events or otherwise.

Investor Relations Dave Demarest (305) 546-7640

Earth Science Tech Nickolas S. Tabraue, P/D/COO (305) 615-2118

Categories
Cannabis Oils Cannabis Plant Hemp Oil In the News Industrial Hemp Latest News Marketing Press Releases Top Stories

Earth Science Tech Announces Highly Anticipated New Revamp Industrial Hemp Products Launch Date & Forecasts Highest Grossing Month

Doral, FL, February 8, 2018 (GLOBE NEWSWIRE) – Earth Science Tech (OTC PINK: ETST) (“ETST” or the “Company”), an innovative biotech company focused on the cannabinoid (CBD), nutraceutical and pharmaceutical fields, as well as on R&D for certain medical devices, today announces launch date on the Company’s highly anticipated new revamp industrial hemp products and forecasts highest grossing month.

Monday, February 12, 2018 is the official launch dat foe the Company’s highly anticipated High Grade Full Spectrum Cannabinoids new revamp products and marketing strategy, announced early December 2017.

High Grade Full Spectrum Cannabinoids is composed of Netherland CO2 supercritical extracted organically grown unfiltered industrial hemp. The Company originally was planning on using American industrial hemp but, was able to secure a reliable high quality source in Europe to continue offering European industrial hemp causing the slight delay in launching. ETST will be one of the first companies to market it’s industrial hemp product as a Cannabinoid Complex, disclosing the mgs of each Cannabinoid, (CBD, CBDV, CBG, CBC, CBN, & CBDA). Cannabinoid complex is naturally occurring in the 7% CBD industrial hemp plant used and is rich in Terpenes, and Saponins as well. Mixed, bottled,  and packaged in the U.S. at a CGMP facility, the Company’s High Grade Full Spectrum Cannabinoids offer the highest consistent quality that current end users trust and carry forward. Preorders are being accepted online.

Since the announcement last year on our new revamp, Mr. Checkout distributor launched last week, and new veteran Chef Sales Officer, (CSO), the exponential demand has the Company forecast the highest revenue month to date. The Company currently has new chain stores, clinics, and health shops eagerly waiting for the launch to place their orders.

Nickolas S. Tabraue, ETST’s president, director and COO concludes, “the feedback alone  the visual have been positively overwhelming. Thanks to our new CSO our sales effective growing sales team along with our CLO’s product education guidance we look have a grand presence domestically and truly stand out in the CBD industry. I would like to update our stakeholders that our audit looks to be done by the end of next week followed by the Tier II Reg A+ submission and plan on announcing completion as well as other materials progress ”

About Earth Science Tech (ETST): Earth Science Tech has among the highest quality, purity and full-spectrum high-grade hemp CBD (cannabidiol) oil on the market. Made using the superior supercritical CO2 liquid extraction, ETST’s CBD oil is 100% natural and organic. The company’s research, performed alongside the University of Central Oklahoma and DV Biologics laboratory, demonstrates that ETST is the top nutritional and dietary supplement brand for high-grade hemp CBD oil.

To learn more and to buy CBD Hemp Oil, please visit: www.earthsciencetech.com

About Earth Science Pharmaceutical: Earth Science Pharmaceutical, Inc. is a wholly owned subsidiary of Earth Science Tech (ETST). Earth Science Pharmaceutical is focused on becoming a world leader in the development of low cost, non-invasive diagnostic tools, medical devices, testing processes and vaccines for STIs (sexually transmitted infections and/or diseases). Earth Science Pharmaceutical CEO Dr. Michel Aubé, a renowned scientist, is committed to help grow ETST in the medical and pharmaceutical industry.

To learn more please visit: www.EarthSciencePharmaceutical.com

About Cannabis Therapeutics: Cannabis Therapeutics, Inc. is a wholly owned subsidiary of Earth Science Tech (ETST). Cannabis Therapeutics was formed as an emerging biotechnology company poised to become a world leader in cannabinoid research and development for a broad line of cannabis cannabinoid-based pharmaceuticals, nutraceuticals, as well as other products & solutions. Cannabis Therapeutics’ mission it to help change the health care landscape by introducing its proprietary cannabis-cannabinoid-based products made for both the pharmaceutical and retail consumer markets worldwide.

To learn more please visit: www.CannabisThera.com

About KannaBidioiD: KannaBidioid, Inc. is wholly owned subsidiary of Earth Science Tech (ETST). KannaBidioid is focused in the recreational space to manufacture and distribute vapes/e-liquids and gummy edibles in the recreational space formulated by its unique Kanna and CBD formula. Kanna and CBD synergistically enhance one another, providing optimal relaxation, an uplifting sensation, enhance focus, and help with nicotine addiction based on their properties.

To learn more please visit: www.KannaBidioiDInc.com

SAFE HARBOR ACT: Forward-Looking Statements are included within the meaning of Section 27A of the Securities Act of 1933, and Section 21E of the Securities Exchange Act of 1934, as amended. All statements regarding our expected future financial position, results of operations, cash flows, financing plans, business strategy, products and services, competitive positions, growth opportunities, plans and objectives of management for future operations, including words such as “anticipate,” “if,” “believe,” “plan,” “estimate,” “expect,” “intend,” “may,” “could,” “should,” “will,” and other similar expressions are forward-looking statements and involve risks, uncertainties and contingencies, many of which are beyond our control, which may cause actual results, performance, or achievements to differ materially from anticipated results, performance, or achievements. We are under no obligation to (and expressly disclaim any such obligation to) update or alter our forward-looking statements, whether as a result of new information, future events or otherwise.

Investor Relations Dave Demarest (305) 546-7640

Earth Science Tech Nickolas S. Tabraue, P/D/COO (305) 615-2118

Categories
Cannabis Oils Hemp Oil In the News Industrial Hemp Latest News Marketing Press Releases

Earth Science Tech Announces Launch Dates & Forecasts for Highly-Anticipated, Revamped Industrial Hemp Products

Doral, FL, Feb. 08, 2018 (GLOBE NEWSWIRE) — Earth Science Tech (OTC PINK: ETST) (“ETST” or the “Company”), an innovative biotech company focused on the cannabinoid (CBD), nutraceutical and pharmaceutical fields, as well as on R&D for certain medical devices, today announced launch date for the Company’s highly-anticipated, revamped industrial hemp Cannabidiol (CBD) products, which lead to forecast updates reflecting to a record-high monthly revenue.

February 13, 2018 is the official launch date for the Company’s highly anticipated High Grade Full Spectrum Cannabinoids product, and corresponding marketing strategy, announced early December 2017.

High Grade Full Spectrum Cannabinoids is composed of European CO2, supercritical extracted, organically grown, and unfiltered industrial hemp. The Company was originally planning on using American industrial hemp but was able to secure a reliable high-quality source in Europe to continue offering European industrial hemp, which led to slight delays from the original launch time frame. ETST will be one of the first companies to market its industrial hemp product as a Cannabinoid Complex instead of CBD, disclosing the milligrams (mg) of each Cannabinoid (CBD, CBDV, CBG, CBC, CBN, & CBDA). Cannabinoid complex is naturally occurring in the industrial hemp plant used, and is rich in Terpenes, and Saponins. Mixed, bottled, and packaged in the U.S. at a CGMP facility, the Company’s High Grade Full Spectrum Cannabinoids offer the highest therapeutic quality that current end-users trust and carry forward. Preorders are currently being accepted online.

Since last year’s announcement on product and marketing strategy revamp, Mr. Checkout distributor launched last week, and new veteran Chef Sales Officer, (CSO), the exponential demand increase has led the Company to revise forecasts to reflect what is anticipated to be the highest revenue month to date. The Company has new chain stores, clinics, and health shops eagerly waiting for the official launch to place their initial orders.

Nickolas S. Tabraue, ETST’s president, director and COO concludes, “Between appointing a new Chief Sales Officer, launching revamped industrial hemp products with fresh branding and marketing strategies, and our new distributor Mr. Checkout, we are on track for a record-setting revenue month. We’ve made clear that we intend to make 2018 our breakout year, and we are laying a strong foundation in this first quarter. We will continue to provide updates on our material events as we can.”

“While much of the up-listing and Reg A+ offering processes are out of our hands, we want to reassure our shareholders that we have worked hard to prepare the required paperwork for our audit and offering filings. We are prioritizing transparency and creating lasting value for our stakeholders and are committed to up-listing to the QB tier of the OTC Markets this year. We will provide updates as progress is made.”